Idarubicin hydrochloride Injection 20 mg in 20 mL (2)

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Laadi alla Avaliku hindamisaruande (PAR)
14-05-2019

Toimeaine:

idarubicin hydrochloride, Quantity: 1 mg/mL

Saadav alates:

Pfizer (Perth) Pty Ltd

Ravimvorm:

Injection, solution

Koostis:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Manustamisviis:

Intravenous Infusion

Ühikuid pakis:

1 x 20 mL

Retsepti tüüp:

(S1) This Schedule is intentionally blank

Näidustused:

Idamycin PFS Injection in combination with other approved anti leukemic drugs is indicated for the treatment of acute myeloid leukemia (AML) in adults. This includes the French-American-British (FAB) classifications M1 through M7.

Toote kokkuvõte:

Visual Identification: Plastic vials containing a red-orange, clear, mobile solution.; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Volitamisolek:

Listed (Export Only)

Loa andmise kuupäev:

2019-05-03